[Lani]

I am currently travelling, but have taken your request to heart. I am hoping to

(but not sure I can) attend both the AACR annual meeting and the ASCO annual

meeting and will try to talk with poster presenters as possible. Drug

companies are usually very tight lipped about problems, but the young

researchers who present posters are often much more communicative.

Drug companies are required to do post-marketing surveillance to follow the

number of people with side effects AFTER the drug is approved. During the

Trials phase they know any adverse news will negatively affect their stock

price and it seems there are few interval reports. I don't know what the

rules/laws are on reporting adverse effects in trials. I will see if I can find out during one of these meetings.